Back
Structure Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Sell
32
GPCR
Structure Therapeutics
Last Price:
33.44
Seasonality Move:
-14.82%
Sell
37
LLY
Eli Lilly and
Last Price:
747.82
Seasonality Move:
3.67%
Sell
32
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy, Sell or Hold?
- The current Structure Therapeutics [GPCR] share price is $33.41. The Score for GPCR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $748.01. The Score for LLY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPCR Stock Price Chart
What is Structure Therapeutics's stock price today?
-
The Structure Therapeutics share price today is $33.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $748.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing selling pressure, which indicates risk of future bearish movement.
GPCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.86 | Sell |
Relative Strength Index (14 RSI): | 41.58 | Sell |
Chaikin Money Flow: | 882035 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.2 - 39.9) | Sell |
Bollinger Bands (100): | (35.54 - 41.32) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -37.29 | Sell |
Relative Strength Index (14 RSI): | 32.13 | Sell |
Chaikin Money Flow: | -2278865 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (761.68 - 879.8) | Sell |
Bollinger Bands (100): | (819.36 - 941.38) | Sell |
GPCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.62 | Sell |
20-day SMA: | 36.75 | Sell |
50-day SMA: | 38.81 | Sell |
200-day SMA: | 39.76 | Sell |
8-day EMA: | 33.58 | Sell |
20-day EMA: | 35.75 | Sell |
50-day EMA: | 37.61 | Sell |
200-day EMA: | 39.17 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 756.56 | Sell |
20-day SMA: | 800.8 | Sell |
50-day SMA: | 865.08 | Sell |
200-day SMA: | 834.92 | Sell |
8-day EMA: | 759.78 | Sell |
20-day EMA: | 796.19 | Sell |
50-day EMA: | 842.15 | Sell |
200-day EMA: | 811.11 | Sell |
Structure Therapeutics Earnings Growth & GPCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.88 per share, and an increase next year of $9.44 per share.
Structure Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |